Development and optimization of OspC chimeritope vaccinogens for Lyme disease.

This study highlights the ability of OspC chimeritopes to serve as vaccinogens that trigger potentially broadly protective Ab responses. In addition to the current use of an OspC chimeritope in a canine LD vaccine, chimeritopes can serve as key components of human LD subunit vaccines.
PMID: 31959423 [PubMed - as supplied by publisher]

Source: Vaccine - January 16, 2020 Category: Allergy & Immunology Authors: Izac JR, O'Bier NS, Oliver LD, Camire AC, Earnhart CG, LeBlanc Rhodes DV, Young BF, Parnham SR, Davies C, Marconi RT Tags: Vaccine Source Type: research